# Local Delivery of Paclitaxel Via the TAPAS Catheter to Prevent Restenosis From Percutaneous Femoropopliteal Intervention

> **NCT01599078** · NA · UNKNOWN · sponsor: **Midwest Cardiovascular Research Foundation** · enrollment: 100 (estimated)

## Conditions studied

- Restenosis
- Peripheral Arterial Disease

## Interventions

- **DRUG:** Paclitaxel
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01599078
- **Lead sponsor:** Midwest Cardiovascular Research Foundation
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-01
- **Primary completion:** 2013-01
- **Final completion:** 2014-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2012-05-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01599078

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01599078, "Local Delivery of Paclitaxel Via the TAPAS Catheter to Prevent Restenosis From Percutaneous Femoropopliteal Intervention". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01599078. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*